Ampreloxetine
| Code | Size | Price |
|---|
| TAR-T26622-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Ampreloxetine, a norepinephrine and 5-HT reuptake inhibitor, is used potentially for treatment of fibromyalgia.
CAS:
1227056-84-9
Formula:
C18H19ClF3NO
Molecular Weight:
357.8
Pathway:
Neuroscience|GPCR/G Protein
Purity:
0.98
SMILES:
Cl.Fc1cc(F)c(OCc2ccccc2C2CCNCC2)c(F)c1
Target:
Norepinephrine|5-HT Receptor
References
1. Smith JA, Bourdet DL, Daniels OT, Ding YS, Gallezot JD, Henry S, Kim KH, Kshirsagar S, Martin WJ, Obedencio GP, Stangeland E, Tsuruda PR, Williams W, Carson RE, Patil ST. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor. Int J Neuropsychopharmacol. 2014 Dec 13;18(2). pii: pyu027. doi: 10.1093/ijnp/pyu027. Erratum in: Int J Neuropsychopharmacol. 2015 Apr;18(6). pii: pyv033. doi: 10.1093/ijnp/pyv033. Patil, D L [corrected to Bourdet, D L]. PubMed PMID: 25522383; PubMed Central PMCID: PMC4368888.